Regenerative Medicine bill introduced in US
This article was originally published in RAJ Devices
Executive Summary
Legislation has been introduced in the US House of Representatives that would establish grant programmes to accelerate the availability of regenerative medicine therapies and research tools, fund regulatory research at the US Food and Drug Administration and create a multiagency co-ordinating council within the Department of Health and Human Services1.